Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 6, 2015, Pages 1223-1229

  Vlieghe, E R ^a   Huang, T D ^b   Phe, T ^c   Bogaerts, P ^b   Berhin, C ^b   De Smet, B ^a   Peetermans, W E ^d   Jacobs, J A ^a,e   Glupczynski, Y ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c Sihanouk Hospital Centre of Hope   (Cambodia)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTEREMIA; CAMBODIA; DNA SEQUENCE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; ESCHERICHIA COLI; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CAMBODIA; CEFOTAXIME; CEPHALOSPORINS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84940000058     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2350-9     Document Type: Article

References (30)

1. Schwaber MJ, Navon-Venezia S, Kaye KS et al (2006) Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262
2. Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60:913–920
3. Peirano G, Pitout JD (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35:316–321
4. Hawkey PM (2008) Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 14(Suppl 1):159–165
5. Cao V, Lambert T, Nhu DQ et al (2002) Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 46:3739–3743
6. Anunnatsiri S, Towiwat P, Chaimanee P (2012) Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. Southeast Asian J Trop Med Public Health 43:1169–1177
7. Apisarnthanarak A, Kiratisin P, Saifon P et al (2007) Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case–case–control study. Am J Infect Control 35:606–612
8. Ruppé E, Hem S, Lath S et al (2009) CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis 15:741–748
9. Vlieghe ER, Phe T, De Smet B et al (2013) Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns. PLoS One 8:e59775
10. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530–538
11. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. CLSI document M100-S22. ISBN: 1-56238-785-5. CLSI, Wayne
12. Bogaerts P, Rezende de Castro R, de Mendonça R et al (2013) Validation of carbapenemase and extended-spectrum beta-lactamase multiplex endpoint PCR assays according to ISO 15189. J Antimicrob Chemother 68:1576–1582
13. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153–2162
14. Clermont O, Dhanji H, Upton M et al (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64:274–277
15. Sheng WH, Badal RE, Hsueh PR; SMART Program (2013) Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 57:2981–2988
16. Ensor VM, Shahid M, Evans JT et al (2006) Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58:1260–1263
17. Kanamori H, Navarro RB, Yano H et al (2011) Molecular characteristics of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. Acta Trop 120:140–145
18. Cao X, Cavaco LM, Lv Y et al (2011) Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J Clin Microbiol 49:2496–2501
19. Park SH, Byun JH, Choi SM et al (2012) Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 12:149
20. Shu JC, Chia JH, Kuo AJ et al (2010) A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol Infect 138:253–263
21. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61:273–281
22. Coque TM, Novais A, Carattoli A et al (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14:195–200
23. Suzuki S, Shibata N, Yamane K et al (2009) Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63:72–79
24. Stoesser N, Crook DW, Moore CE et al (2012) Characteristics of CTX-M ESBL-producing Escherichia coli isolates from the Lao People’s Democratic Republic, 2004–09. J Antimicrob Chemother 67:240–242
25. Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14
26. Novais A, Pires J, Ferreira H et al (2012) Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob Agents Chemother 56:3973–3976
27. Chung HC, Lai CH, Lin JN et al (2012) Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56:618–622
28. Pitout JD, Laupland KB, Church DL et al (2005) Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49:4667–4670
29. Vlieghe ER, Sary S, Lim K et al (2013) First National Workshop on Antibiotic Resistance in Cambodia: Phnom Penh, Cambodia, 16–18 November 2011. J Global Antimicrobial Resistance 1:31–34
30. Paterson DL (2004) “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38(Suppl 4):S341–S345